ENKAM PHARMACEUTICALS A/S

corporate_fareorganization

Web page: http://wwww.enkam.com

Country: Denmark

ENKAM PHARMACEUTICALS A/S

- Funding / Projects
  (4)

4 Projects, page 1 of 1

STEMCAM (A IAPP on the Role of NCAM in Stem Cell Differentiation)
assignment_turned_inProject2010 - 2014Partners:BIOT, KLINIKUM DER UNIVERSITAET ZU KOELN, UNIGE, Stemcell Technologies, ENKAM PHARMACEUTICALS A/S
BIOT,
KLINIKUM DER UNIVERSITAET ZU KOELN,
UNIGE,
Stemcell Technologies,
ENKAM PHARMACEUTICALS A/S
Funder: European Commission Project Code: 251186
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
TREATPOLYQ (TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases.)
assignment_turned_inProject2011 - 2015Partners:Université Paris Diderot, THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE, KI, Technion – Israel Institute of Technology, AC IMMUNE SA +11 partners
Université Paris Diderot,
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE,
KI,
Technion – Israel Institute of Technology,
AC IMMUNE SA,
University of Tübingen,
NsGene,
CNRS,
Lund University,
Institute Curie,
CNC,
ENKAM PHARMACEUTICALS A/S,
MPG,
H. LUNDBECK A/S,
Siena Biotech (Italy),
KCL
Funder: European Commission Project Code: 264508
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
NEUROFGL (Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders)
Open Access Mandate for Publications assignment_turned_inProject2012 - 2014Partners:Qualissima (France), ENKAM PHARMACEUTICALS A/S, UCPH, FORENAP PHARMA, PSYCHIATRICKE CENTRUM PRAHA +2 partners
Qualissima (France),
ENKAM PHARMACEUTICALS A/S,
UCPH,
FORENAP PHARMA,
PSYCHIATRICKE CENTRUM PRAHA,
KLINIKUM DER UNIVERSITAET ZU KOELN,
H. LUNDBECK A/S
Funder: European Commission Project Code: 278006
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
MEMSTICK (Synaptic mechanisms of memory loss: novel cell adhesion molecules as therapeutic targets)
assignment_turned_inProject2008 - 2011Partners:ENKAM PHARMACEUTICALS A/S, NEOLOCH, NENCKI, KUL, EPFL +4 partners
ENKAM PHARMACEUTICALS A/S,
NEOLOCH,
NENCKI,
KUL,
EPFL,
SCIENTIFIC PROJECT MANAGEMENT,
CSIC,
MPG,
OU
Funder: European Commission Project Code: 201600
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu
more_vert
linkLink to
shareshareShare
uploaduploadDeposit
codecodeEmbed
Select content type to embed
All Research products
arrow_drop_down
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

ENKAM PHARMACEUTICALS A/S

ENKAM PHARMACEUTICALS A/S

4 Projects, page 1 of 1

STEMCAM (A IAPP on the Role of NCAM in Stem Cell Differentiation)

TREATPOLYQ (TreatPolyQ – Industrial Academic Initial Training Network towards treatment of Polyglutamine Diseases.)

NEUROFGL (Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders)

MEMSTICK (Synaptic mechanisms of memory loss: novel cell adhesion molecules as therapeutic targets)

Loading